Producing quality clinical candidates less prone to late stage failure is greatly facilitated by better integration of the relevant high throughput functions and the inclusion of ADME/toxicology further upstream in the discovery process. We describe the tasks and their integration in the context of the design, make and test triad.
References
1.
Leo AJ: Critique of recent comparison of log P calculation methods. Chem Pharm Bull1995;43:976-978.
2.
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliver Rev1997;23:3-25.
3.
van Rossum G, de Boer J: Interactively testing remote servers using the Python programming language. CWI Q1991;4(4):283-303.
4.
Ousterhout JK: The Sprite network operating system. IEEE Coniput Maga ine1998.
5.
Cortes R (ed): Conmbinatorial Libraries-Synthesis, Screenigl anld Application Potential. Berlin: Walter de Gruyer. 1996.
6.
Jung G (ed): Comnbinatorial Clemistry-Synthesis, Analysis, Screening. Weinheim: Wiley-VCH. 1999.
7.
Banks P, Gosselin M, Prystay L: Fluorescence polarization assays for high throughput screening of G protein-coupled receptors. J Biomol Screen2000;5:159-167.
8.
Kelly JH, Sussman NL: A fluorescent cell-based assay for cytochrome P-450 isozyme 1A2 induction and inhibition. J Biomol Screen2000;5:249-253.
